Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is measuring whether patients survive two years without serious setbacks like disabling stroke, needing the device replaced, or ending up on IV inotropes — given those specific risks are being studied, what does my current condition suggest about my personal likelihood of facing any of them?
2. 2Since this trial has no assigned phase, meaning it's being evaluated more like a real-world effectiveness study than an early safety test, how confident are you in what's already known about the safety of this type of mechanical circulatory support device for someone with my stage of heart failure?
3. 3The trial also includes patients with pulmonary hypertension — do I have that complication, and does it change how risky or appropriate this kind of mechanical circulatory support might be for me specifically?
4. 4One of the outcomes they're tracking is needing to be listed urgently for a heart transplant — does pursuing this trial affect my standing or eligibility on the transplant list, and should we be thinking about transplant as a parallel path?
5. 5Before considering this trial, are there standard heart failure treatments I haven't tried yet that might be worth exhausting first, or is my condition advancing quickly enough that mechanical circulatory support now makes sense to discuss seriously?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.